0001179110-17-014593.txt : 20171124 0001179110-17-014593.hdr.sgml : 20171124 20171124165501 ACCESSION NUMBER: 0001179110-17-014593 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171121 FILED AS OF DATE: 20171124 DATE AS OF CHANGE: 20171124 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GONZALEZ RICHARD A CENTRAL INDEX KEY: 0001239127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 171221658 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 edgar.xml FORM 4 - X0306 4 2017-11-21 0 0001551152 AbbVie Inc. ABBV 0001239127 GONZALEZ RICHARD A 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 1 1 0 0 Chairman of the Board and CEO Common stock, $0.01 par value 2017-11-21 4 M 0 218193 58.88 A 492030 D Common stock, $0.01 par value 2017-11-21 4 S 0 218193 94.0076 D 273837 D Common stock, $0.01 par value 4600 I By spouse Common stock, $0.01 par value 450 I By step-daughter Common stock, $0.01 par value 450 I By step-son Option (right to buy) 58.88 2017-11-21 4 M 0 218193 0 D 2017-02-19 2025-02-18 Common stock, $0.01 par value 218193 109097 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.75 to $94.34, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reporting person disclaims beneficial ownership of these securities. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Steven L. Scrogham, attorney-in-fact for Richard A. Gonzalez 2017-11-24